Intra-host evolutionary dynamics of hepatitis C virus E2 in treated patients

被引:16
作者
Alfonso, V
Mbayed, VA
Sookoian, S
Campos, RH
机构
[1] Univ Buenos Aires, Fac Farm & Bioquim, Catedra Virol, RA-1113 Buenos Aires, DF, Argentina
[2] Hosp Argerich, Unidad Hepatol, Buenos Aires, DF, Argentina
关键词
D O I
10.1099/vir.0.81084-0
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Hepatitis C virus (HCV) displays high genetic diversity. Inter-host sequence variability may mainly reflect a neutral drift evolution. In contrast, intra-host evolution may be driven by an adaptive selection to host responses to infection. Here, HCV E2 intra-host evolution in two patients during the course and follow-up of successive treatments with IFN-alpha and IFN-alpha/ribavirin was investigated. Phylogenetic analyses suggested that adaptive pressures prompt a continuous selection of viral variants derived from the previous ones (intra-lineage evolution) and/or a swapping of viral lineages during the course of the infection (inter-lineage evolution). Selection would act not only on the phenotypic features of hypervariable, region 1 (HVR1) but also on those of the flanking regions. The pressures operate mainly at the amino acid level, but they also appeared to act on nucleotide sequences. Moreover, HVR1 heterogeneity seemed to be strongly constrained. This work contributes to the knowledge of HCV intra-host evolution during chronicity.
引用
收藏
页码:2781 / 2786
页数:6
相关论文
共 40 条
[21]   Long-term evolution of the hypervariable region of hepatitis C virus in a common-source-infected cohort [J].
McAllister, J ;
Casino, C ;
Davidson, F ;
Power, J ;
Lawlor, E ;
Yap, PL ;
Simmonds, P ;
Smith, DB .
JOURNAL OF VIROLOGY, 1998, 72 (06) :4893-4905
[22]  
Muller R, 1996, J HEPATOL, V24, P52
[23]   The nature of interferon-α resistance in hepatitis C virus infection [J].
Pawlotsky, JM .
CURRENT OPINION IN INFECTIOUS DISEASES, 2003, 16 (06) :587-592
[24]   Evolution of the hepatitis C virus second envelope protein hypervariable region in chronically infected patients receiving alpha interferon therapy [J].
Pawlotsky, JM ;
Germanidis, G ;
Frainais, PO ;
Bouvier, M ;
Soulier, A ;
Pellerin, M ;
Dhumeaux, D .
JOURNAL OF VIROLOGY, 1999, 73 (08) :6490-6499
[25]   Conservation of the conformation and positive charges of hepatitis C virus E2 envelope glycoprotein hypervariable region 1 points to a role in cell attachment [J].
Penin, F ;
Combet, C ;
Germanidis, G ;
Frainais, PO ;
Deléage, G ;
Pawlotsky, JM .
JOURNAL OF VIROLOGY, 2001, 75 (12) :5703-5710
[26]   MODELTEST: testing the model of DNA substitution [J].
Posada, D ;
Crandall, KA .
BIOINFORMATICS, 1998, 14 (09) :817-818
[27]   HEPATITIS-C VIRUS-INFECTION IS ASSOCIATED WITH THE DEVELOPMENT OF HEPATOCELLULAR-CARCINOMA [J].
SAITO, I ;
MIYAMURA, T ;
OHBAYASHI, A ;
HARADA, H ;
KATAYAMA, T ;
KIKUCHI, S ;
WATANABE, Y ;
KOI, S ;
ONJI, M ;
OHTA, Y ;
CHOO, QL ;
HOUGHTON, M ;
KUO, G .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1990, 87 (17) :6547-6549
[28]   High-resolution phylogenetic analysis of hepatitis C virus adaptation and its relationship to disease progression [J].
Sheridan, I ;
Pybus, OG ;
Holmes, EC ;
Klenerman, P .
JOURNAL OF VIROLOGY, 2004, 78 (07) :3447-3454
[29]   A hyperimmune serum against a synthetic peptide corresponding to the hypervariable region 1 of hepatitis C virus can prevent viral infection in cell cultures [J].
Shimizu, YK ;
Igarashi, H ;
Kiyohara, T ;
Cabezon, T ;
Farci, P ;
Purcell, RH ;
Yoshikura, H .
VIROLOGY, 1996, 223 (02) :409-412
[30]   Viral heterogeneity of the hepatitis C virus [J].
Simmonds, P .
JOURNAL OF HEPATOLOGY, 1999, 31 :54-60